Neurological assessment and degree of disability of leprosy patients: observation at diagnosis and at discharge

  • Carla Andréa Avelar Pires
  • Sabrina Sampaio Bandeira
  • Gabriela Ferreira Rocha UEPA
  • Marcella Silva Maia UEPA
  • Ana Carolina Magalhães Nascimento
  • Márcia Moraes dos Prazeres
  • Suzana Maria Klautau Ferreira
  • Anderson Phelipe Dias Sabry Azar
  • Heraldo Hebert Mauro Neto
  • Rafael Oliveira Chaves
  • Adriana Kamilly Leitão Pitman Machado

Abstract

Background: Caring for leprosy patients requires neurological assessment for prevention of potential physical disabilities. This study focused on the neurological impairment and degree of physical incapacity (DI) at the time of the diagnosis and at discharge of leprosy patients from Dermatology Department of the University of the State of Pará.


Methods and findings: It was a cross-sectional, observational study based on the medical records, neurological assessment and DI of 14 patients assisted at a referral service between 2012 and 2016, applying descriptive statistical analysis. At diagnosis were observed patients with decreased abduction forces of the 5th finger (14.28%), extension of hallux and foot dorsiflexion (10.72%); loss of protective sensitivity in the ulnar nerve area (3.57%) and tibial nerve area (25%); 7.15% of thickened ulnar nerve; DI 0 (64.28%) and DI 1 (35.72%). At discharge, 10.72% of the patients showed decreased abduction of the 5th finger, extension of hallux and foot dorsiflexion (14.28%); loss of protective sensitivity just in the tibial nerve area (17.87%); 4.28% of thickened ulnar nerve; DI 0 (78.57%) and DI 1 (21.43%).


Conclusions: Therefore, most of the patients had normal neurological assessment and DI 0 at both moments, with reduction of alterations in discharge, except for the fibular nerve. Thus, it is highlighted the primary role of the health team, which constitutes one of the main agents promoters of health education, especially when it comes to preventing disabilities in leprosy.

References

1. World Health Organization. Weekly epidemiological record.
2015; (36): 461-76.
2. Ministério da Saúde. Diretrizes para vigilância, atenção e
eliminação da hanseníase como problema de saúde pública:
manual técnico-operacional. 2016. [Internet]. Brasília: Brasil;
2016. [citado em 2017 dez 19] Available in: http://portalsaude.
saude.gov.br/images/pdf/2016/fevereiro/04/diretrizeseliminacao-hanseniase-4fev16-web.pdf.
3. Mesquita R. et al. Avaliação neurofuncional em pacientes com
Hanseníase. Rev Bras Promoç Saúde. 2014; 27 (2): 247-55.
4. Ministério da Saúde. Secretaria de Vigilância em Saúde.
Departamento de Vigilância Epidemiológica. Manual de
Prevenção de Incapacidades. 2008. [Internet]. Brasília; 2008.
[citado em 2017 dez 19] Available in: http://portalsaude.
saude.gov.br/index.php/o-ministerio/principal/leia-mais-oministerio/707-secretaria-svs/vigilancia-de-a-a-z/hanseniase/l2hanseniase/13717-publicacoes-hanseniase.
5. Basombrio, G. et al. Draft report of classification Committee.
In: Congresso Internacional de Leprologia; 1953; Madrid:
Associación Internacional de la Lepra; 1953. p. 75- 86.
6. World Health Organization. Chemotherapy of leprosy for control
programmes: report of a WHO study group. 1982; (675).
7. DATASUS. Taxa incidência de hanseníase segundo Sexo –
Período. 2012. [Internet]. Available in: http://tabnet.datasus.gov.
br/cgi/tabcgi.exe?idb2012/d0206.def..
8. World Health Organization. Global leprosy update, 2013;
disease burden. Weekly epidemiological Record. 2014; 89 (36):
389-400.
9. Monteiro LD. Padrões de comprometimento neural, limitação
de atividade, participação social e fatores associados nas
pessoas em pós alta da hanseníase nos anos de 2004 a 2009,
Araguaína- TO. [Dissertation- Master in Health Public]. Fortaleza
(CE): Universidade Federal do Ceará, 2012.
10. Virmond MCL, Cury Filho M. Tratamento cirúrgico nos membros
superiores e inferiores. In: Alves ED, Ferreira TL, Ferreira IN.
Hanseníase: avanços e desafios. 1.ª ed. Brasília: NESPROM- Unb,
2014. p. 305-332.
11. Tavares JP et al. Fisioterapia no atendimento de pacientes com
hanseníase: um estudo de revisão. Rev. amazônia: science &
health. 2013; 1(2):37-43.
12. Brandão, JG. Incapacidade física durante o tratamento
poliquimioterápico dos pacientes de hanseníase no Brasil
nas coortes de cura de casos novos dos anos de 2010 e
2011. [Dissertation –Master in Health Science]. Brasília (DF):
Universidade de Brasília, 2013.
13. Borges MGL et al. O cuidado hospitalar na hanseníase: um perfil
do Estado do Pará de 2008 a 2014. Rev. Hansen. Int.. 2015;
40(1): 25-32.
Published
2018-07-29
How to Cite
PIRES, Carla Andréa Avelar et al. Neurological assessment and degree of disability of leprosy patients: observation at diagnosis and at discharge. International Archives of Medicine, [S.l.], v. 11, july 2018. ISSN 1755-7682. Available at: <http://imedicalsociety.org/ojs/index.php/iam/article/view/2824>. Date accessed: 21 aug. 2018. doi: https://doi.org/10.3823/2573.
Section
Infectious Diseases